Combined hepatocellular cholangiocarcinoma: A case report and review of literature

Digestive Diseases and Sciences

Volumn 58, Issue 7, 2013, Pages 2114-2123

  Singh, Shailender ^a   Chakraborty, Subhankar ^b   Bonthu, Neelima ^c   Radio, Stanley ^b   Hussain, Shahid M ^b   Sasson, Aaron ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c NORTH SHORE MEDICAL CENTER   (United States)

Author keywords

Cholangiocarcinoma; Diagnosis; Hepatocellular carcinoma; Prognosis; Radiation; SEER; Surgery

Indexed keywords

GADOLINIUM;

ABDOMINAL PAIN; AGED; ARTICLE; BILE DUCT CARCINOMA; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; LIVER RESECTION; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROGNOSIS; TUMOR BIOPSY;

AGED; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CARCINOMA, HEPATOCELLULAR; CHOLANGIOCARCINOMA; HUMANS; LIVER NEOPLASMS; MALE; NEOPLASMS, COMPLEX AND MIXED;

EID: 84879842257     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-013-2585-1     Document Type: Article

References (32)

1. Goodman ZD, Ishak KG, Langloss JM, Sesterhenn IA, Rabin L. Combined hepatocellular-cholangiocarcinoma. A histologic and immunohistochemical study. Cancer. 1985;55:124-135.
2. [No authors listed]. Primary liver cancer in Japan. Clinicopathologic features and results of surgical treatment. Liver cancer study group of Japan. Ann Surg. 1990;211:277-287.
3. Jarnagin WR, Weber S, Tickoo SK, et al. Combined hepatocellular and cholangiocarcinoma: Demographic, clinical, and prognostic factors. Cancer. 2002;94:2040-2046.
4. Ishak KG, Anthony PP, Sobin LH. Histological Typing of the Liver. International Histological Classification of Tumours. WHO. 2nd ed. Hong Kong: Springer; 1994.
5. Panjala C, Senecal DL, Bridges MD, et al. The diagnostic conundrum and liver transplantation outcome for combined hepatocellular-cholangiocarcinoma. Am J Transplant. 2010;10:1263-1267.
6. Allen RA, Lisa J. Combined liver cell and bile duct carcinoma. Am J Pathol. 1949;25:647-655.
7. Wells H. Primary carcinoma of the liver. Am J Sci. 1903;126:403-417.
8. The Liver Cancer Study Group of Japan. The general rules for the clinical and pathological study of primary liver cancer. Jpn J Surg. 1989;19:98-129.
9. Lee JH, Chung GE, Yu SJ, et al. Long-term prognosis of combined hepatocellular and cholangiocarcinoma after curative resection comparison with hepatocellular carcinoma and cholangiocarcinoma. J Clin Gastroenterol. 2011;45:69-75.
10. Maeda T, Adachi E, Kajiyama K, Sugimachi K, Tsuneyoshi M. Combined hepatocellular and cholangiocarcinoma: Proposed criteria according to cytokeratin expression and analysis of clinicopathologic features. Hum Pathol. 1995;26:956-964.
11. Leong AS, Sormunen RT, Tsui WM, Liew CT. Hep par 1 and selected antibodies in the immunohistological distinction of hepatocellular carcinoma from cholangiocarcinoma, combined tumours and metastatic carcinoma. Histopathology. 1998;33:318-324.
12. Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature. 2001;414:105-111.
13. Alison MR. Liver stem cells: Implications for hepatocarcinogenesis. Stem Cell Rev. 2005;1:253-260.
14. Wu XZ, Chen D. Origin of hepatocellular carcinoma: role of stem cells. J Gastroenterol Hepatol. 2006;21:1093-1098.
15. Fujii H, Zhu XG, Matsumoto T, et al. Genetic classification of combined hepatocellular-cholangiocarcinoma. Hum Pathol. 2000;31:1011-1017.
16. Yano H, Iemura A, Haramaki M, et al. A human combined hepatocellular and cholangiocarcinoma cell line (KMCH-2) that shows the features of hepatocellular carcinoma or cholangiocarcinoma under different growth conditions. J Hepatol. 1996;24:413-422.
17. Woo HG, Lee JH, Yoon JH, et al. Identification of a cholangiocarcinoma- like gene expression trait in hepatocellular carcinoma. Cancer Res. 2010;70:3034-3041.
18. Zhou YM, Yang JM, Wang B, Xu F, Tong Y, Li DQ. Combined hepatocellular carcinoma and cholangiocarcinoma: a case report and review of the literature. Hepatobiliary Pancreat Dis Int. 2007;6:656-659.
19. Taguchi J, Nakashima O, Tanaka M, Hisaka T, Takazawa T, Kojiro M. A clinicopathological study on combined hepatocellular and cholangiocarcinoma. J Gastroenterol Hepatol. 1996;11:758-764.
20. Kassahun WT, Hauss J. Management of combined hepatocellular and cholangiocarcinoma. Int J Clin Pract. 2008;62:1271-1278.
21. Choi BI, Han JK, Kim YI, et al. Combined hepatocellular and cholangiocarcinoma of the liver: sonography, CT, angiography, and iodized-oil CT with pathologic correlation. Abdom Imaging. 1994;19(1):43-46.
22. Sanada Y, Shiozaki S, Aoki H, Takakura N, Yoshida K, Yamaguchi Y. A clinical study of 11 cases of combined hepatocellular-cholangiocarcinoma assessment of enhancement patterns on dynamics computed tomography before resection. Hepatol Res. 2005;32:185-195.
23. Hashimoto T, Nakamura H, Hori S, et al. MR imaging of mixed hepatocellular and cholangiocellular carcinoma. Abdom Imaging. 1994;19(5):430-432.
24. Hwang J, Kim YK, Park MJ, et al. Differentiating combined hepatocellular and cholangiocarcinoma from mass-forming intrahepatic cholangiocarcinoma using gadoxetic acid-enhanced MRI. J Magn Reson Imaging. 2012;36:881-889.
25. Koh KC, Lee H, Choi MS, et al. Clinicopathologic features and prognosis of combined hepatocellular cholangiocarcinoma. Am J Surg. 2005;189:120-125.
26. Nakamura S, Suzuki S, Sakaguchi T, et al. Surgical treatment of patients with mixed hepatocellular carcinoma and cholangiocarcinoma. Cancer. 1996;78:1671-1676.
27. Tickoo SK, Zee SY, Obiekwe S, et al. Combined hepatocellular- cholangiocarcinoma: a histopathologic, immunohistochemical, and in situ hybridization study. Am J Surg Pathol. 2002;26:989-997.
28. Okuda K. Natural history of hepatocellular carcinoma including fibrolamellar and hepato-cholangiocarcinoma variants. J Gastroenterol Hepatol. 2002;17:401-405.
29. Portolani N, Baiocchi GL, Coniglio A, et al. Intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma: a western experience. Ann Surg Oncol. 2008;15:1880-1890.
30. Kim JH, Yoon HK, Ko GY, et al. Nonresectable combined hepatocellular carcinoma and cholangiocarcinoma: analysis of the response and prognostic factors after transcatheter arterial chemoembolization. Radiology. 2010;255:270-277.
31. Sotiropoulos GC. Survival benefit in hepatocellular carcinoma: when an innovative transplant strategy might benefit oncology. Lancet Oncol. 2011;12:611-612.
32. Sapisochin G, Fidelman N, Roberts JP, Yao FY. Mixed hepatocellular cholangiocarcinoma and intrahepatic cholangiocarcinoma in patients undergoing transplantation for hepatocellular carcinoma. Liver Transpl. 2011;17:934-942.